Prediction of malignant hyperthermia susceptibility: statistical evaluation of clinical signs.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  British Journal of Anaesthesia

• Publication date

  1990-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0278-2391(90)90515-4PMID 2334615
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prediction of malignant hyperthermia susceptibility by clinical signs.

  1987cited by this paper
• Prediction of malignant hyperthermia susceptibility by clinical signs.

  1987cited by this paper
• Masseter Muscle Rigidity and Malignant Hyperthermia Susceptibility

  1986cited by this paper
• Suxamethonium spasm. A differential diagnostic conundrum.

  1984cited by this paper
• A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.

  1984cited by this paper
• Malignant hyperthermia--the acute crisis.

  1979cited by this paper
• The analysis of binary data

  1971cited by this paper

• Succinylcholine-triggerred "masseter spasm" may be a variant normal response.

  2013cites this paper
• CHAPTER 37 – Malignant Hyperthermia

  2011cites this paper
• A functional analysis of RYR1 mutations causing malignant hyperthermia : a thesis presented to Massey University in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biochemistry

  2009cites this paper
• Mini-clinical evaluation exercise in anaesthesia training.

  2009cites this paper
• Re-emerging Human Brucellosis, Thailand 2003

  2007cites this paper
• Chapter 31 – Malignant Hyperthermia

  2006cites this paper
• Bedeutung von 3,4- Methylendioxymethamphetamin ("Ecstasy") als Triggersubstanz der Malignen Hyperthermie

  2005cites this paper
• Malignant hyperthermia.

  2003cites this paper
• Malignant hyperthermia and myotonic disorders.

  2002cites this paper
• General pediatric emergencies. Malignant hyperthermia syndrome.

  2001cites this paper
• Malignant hyperthermia: advances in clinical management and diagnosis.

  2000cites this paper
• Management of malignant hyperthermia susceptible parturients.

  1997cites this paper
• Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes.

  1997cites this paper
• Intraoperative complications

  1997cites this paper
• Management of malignant hyperthermia susceptible parturients.

  1997cites this paper
• Neuromuscular transmission and its pharmacological blockade. Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit.

  1997cites this paper
• Sudden unexplained death in a patient with a family history of malignant hyperthermia.

  1997cites this paper
• Malignant hyperthermia: state of the art.

  1997cites this paper
• Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit

  1997cites this paper
• Variants of malignant hyperthermia. Special problems for the paediatric anaesthesiologist

  1996cites this paper
• Small patients may have big problems: Complications of pediatric anesthesia

  1996cites this paper
• Clinical Classification and Incidence of Fulminant and Abortive Malignant Hyperthermia Reactions in Italy

  1996cites this paper
• Malignant Hyperthermia in Austria 1984-1993

  1996cites this paper
• Investigation of malignant hyperthermia susceptibility in Denmark.

  1996cites this paper
• Creatine Kinase Alterations After Acute Malignant Hyperthermia Episodes and Common Surgical Procedures

  1995cites this paper
• [Hypercapnia and mixed acidosis as the only sign of malignant hyperthermia (MH)?].

  1994cites this paper
• Genetic Effects on the Variability of the Halothane and Caffeine Muscle Contracture Tests

  1994cites this paper
• Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.

  1994cites this paper
• [Malignant hyperthermia].

  1994cites this paper
• Suxamethonium — Current controversies

  1993cites this paper
• Masseter spasm after suxamethonium in children.

  1992cites this paper
• Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry.

  1992cites this paper
• Neue Akzente bei der Maligne-Hyperthermie-Diagnostik mittels in-vitro-Kontrakturtest?

  1991cites this paper
• Jaw stiffness--an ill understood condition.

  1991cites this paper
• A case of malignant hyperthermia?

  1991cites this paper
• [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].

  1991cites this paper
• A method for withholding sedatives from patients before obtaining surgical consent.

  1991cites this paper
• Masseter muscle spasm in children.

  1991cites this paper
• Masseter spasm in perspective

  1991cites this paper
• Predicting malignant hyperthermia.

  1990cites this paper